Hikma Pharmaceuticals Plc Director/PDMR Shareholding (6828G)

TIDMHIK

RNS Number : 6828G

Hikma Pharmaceuticals Plc

31 May 2017

Hikma Pharmaceuticals PLC - Vesting of LTIP Awards

LONDON, 31 May 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 29 May 2017 under the 2005 Long Term Incentive Plan ("LTIP") which was completed on 31 May 2017. These awards were automatically exercised by operation of the conditional award and vesting process. The exercise price under the LTIP is GBPnil.

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------ 
 a)   Name                   Said Darwazah 
---  ---------------------  ------------------------------------- 
 2    Reason for the notification 
---  ------------------------------------------------------------ 
 a)   Position/status        Chairman and Chief Executive Officer 
---  ---------------------  ------------------------------------- 
 b)   Initial notification   Initial notification 
       /Amendment 
---  ---------------------  ------------------------------------- 
 3    Details of the issuer, emission allowance market 
       participant, auction platform, auctioneer or 
       auction monitor 
---  ------------------------------------------------------------ 
 a)   Name                   Hikma Pharmaceuticals PLC 
---  ---------------------  ------------------------------------- 
 b)   LEI                    549300BNS685UXH4JI75 
---  ---------------------  ------------------------------------- 
 4    Details of the transaction(s): section to be 
       repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; 
       and (iv) each place where transactions have 
       been conducted 
---  ------------------------------------------------------------ 
 a)   Description            Description: Ordinary shares of 10 
       of the financial       pence each (Shares) 
       instrument,            ID Code: GB00B0LCW083 
       type of instrument 
       and identification 
       code 
---  ---------------------  ------------------------------------- 
 b)   Nature of              Shares acquired from vesting of the 
       the transaction        conditional awards on 29 May 2017 
                              under the 2005 LTIP. 
---  ---------------------  ------------------------------------- 
 c)   Price(s) and           Price(s): GBPnil 
       volume(s)              Volume(s): 52,164 
---  ---------------------  ------------------------------------- 
 d)   Aggregated             N/A 
       information 
---  ---------------------  ------------------------------------- 
 e)   Date of the            30 May 2017 
       transaction 
---  ---------------------  ------------------------------------- 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
---  ---------------------  ------------------------------------- 
 
 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ----------------------------------------------------------- 
 a)   Name                   Mazen Darwazah 
---  ---------------------  ------------------------------------ 
 2    Reason for the notification 
---  ----------------------------------------------------------- 
 a)   Position/status        Executive Vice Chairman 
---  ---------------------  ------------------------------------ 
 b)   Initial notification   Initial notification 
       /Amendment 
---  ---------------------  ------------------------------------ 
 3    Details of the issuer, emission allowance market 
       participant, auction platform, auctioneer or 
       auction monitor 
---  ----------------------------------------------------------- 
 a)   Name                   Hikma Pharmaceuticals PLC 
---  ---------------------  ------------------------------------ 
 b)   LEI                    549300BNS685UXH4JI75 
---  ---------------------  ------------------------------------ 
 4    Details of the transaction(s): section to be 
       repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; 
       and (iv) each place where transactions have 
       been conducted 
---  ----------------------------------------------------------- 
 a)   Description            Description: Ordinary shares of 10 
       of the financial       pence each (Shares) 
       instrument,            ID Code: GB00B0LCW083 
       type of instrument 
       and identification 
       code 
---  ---------------------  ------------------------------------ 
 b)   Nature of              Shares acquired from vesting of the 
       the transaction        conditional awards on 29 May 2017 
                              under the 2005 LTIP. 
---  ---------------------  ------------------------------------ 
 c)   Price(s) and           Price(s): GBPnil 
       volume(s)              Volume(s): 38,088 
---  ---------------------  ------------------------------------ 
 d)   Aggregated             N/A 
       information 
---  ---------------------  ------------------------------------ 
 e)   Date of the            30 May 2017 
       transaction 
---  ---------------------  ------------------------------------ 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
---  ---------------------  ------------------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHGIGDULXXBGRB

(END) Dow Jones Newswires

May 31, 2017 04:38 ET (08:38 GMT)

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2024 to May 2024